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Introduction
Since the invention of electrospinning in the early 20th cen-
tury,1 there has been enormous activity in this area during the 
last two decades,2–5 with more than 1500 annual reports and 
15,000 publications being written on the subject (Figure 1). 
This technology has also been considered as highly useful 
for fabricating scaffolds for culture of tissue cells and the 
treatment of damaged and diseased tissues, including blood 
vessels, muscles, skins, tendons, ligaments, cartilage, nerves,   
and bones.6,7
The hierarchical structures of electrospun materials, 
namely, continuous nanostructured fibers with diameters of 
tens of nanometers over a few micrometers, are considered 
to mimic the native tissue structures that comprise matrices 
surrounding tissue cells.7 When compared to the flat sur-
faces of dense materials, nanofibrous networks feature sub-
stantially increased surface area with directional fiber 
alignment, which helps cells to recognize more sites for 
adherence and guides them to spread and migrate in spe-
cific directions.8 Technological advances in electrospinning 
have also sought to improve the capacity of the nanostruc-
tured fibrous matrices for tissue-regeneration processes. 
For example, nanofibers have been aligned to guide neural 
or muscle cells,9 designed with a core–shell structure to 
incorporate therapeutic drugs inside,10 and tailored to have 
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hybrid compositions with appropriate properties such as 
mechanical integrity for hard tissues.11
Among areas relevant to tissue regeneration, this review 
focuses on systems that target bone tissue. This is the tissue 
in which extracellular matrices (ECMs) are essentially 
composed of organic and inorganic nanocomposites. The 
artificial materials must be designed to have the mechanical 
properties needed to sustain loads and should be favorable 
for recruiting cells specific for mineralizing tissues.12 
Recent advances in electrospinning technology related to 
the regeneration of calcified hard tissues are summarized. 
In this review, the design of electrospinning equipment is 
briefly introduced, followed by a review of newly devel-
oped materials for target tissues, potential therapeutic 
applications, and perspectives regarding future directions.
Electrospinning designs
General setup
The essential components of electrospinning equipment 
consist of a power supply, injection pump and nozzle, and a 
conducting collector, as described in Figure 2. The solution 
or slurry kept in a syringe is injected through a nozzle by 
the application of DC electrical power and then collected 
on a conducting substrate. In an electrical field, the solution 
at the nozzle tip becomes unstable as a result of surface ten-
sion and the electrical potential, and a sudden jet spinning 
is achieved upon overcoming the surface tension.3,13 The 
nanofibers generated by the electrospinning have diameters 
ranging from tens of nanometers to several micrometers. 
The power (voltage and current), injection rate, nozzle 
capacity, collector design, and environmental factors such 
as temperature and humidity are possible variables that 
must be controlled. Above all, the type of solution (materi-
als) and the fluid properties such as viscosity, surface ten-
sion, and vapor pressure should be carefully adjusted to 
form a continuous and homogeneous-sized fiber. A new 
design of the apparatus is mainly useful to achieve specific 
forms of nanostructured fibers, such as aligned, core–shell 
structured, or macroporous nanofibers.
Alignment of nanofibers
When the electrospun fiber is aligned, it is considered to 
guide tissue cells in the direction of the fiber, and this is 
particularly relevant in areas of aligned tissues, including 
nerves and muscles. In the case of hard tissues, such as 
bone, the alignment of collagenous fibers is of special 
importance. Calcified bone tissue exhibits different 
mechanical properties depending on the collagen alignment 
in the native structure.14 It has been accepted that strength 
is higher along the direction parallel to the fiber alignment 
than along the direction perpendicular to fiber alignment.3 
Moreover, compared to randomly oriented fibers, the 
aligned fibers exhibited significantly improved resistance 
to tensile stress (˜8–10 fold more) when tested parallel to 
the fiber alignment.15 This alignment of fibers influences 
cell behavior starting from the initial cell spreading and 
elongation (as shown in Figure 3), which in turn influences 
matrix synthesis and possibly differentiation and calcifica-
tion into bone tissues.
Core–shell designs
One promising nozzle design is the core–shell nozzle, as 
described in Figure 4. In most cases, the design originates 
from the need to incorporate drugs inside of the nanofib-
ers. Drugs sheathed inside will be initially protected from 
environmental factors, such as the solvents used for elec-
trospinning. Furthermore, the encapsulated drugs will be 
released past the outer shell layer in a more sustainable 
pattern. This idea has also been proven in some recent 
Figure 2.  Illustration of electrospinning setup consisting of 
a power supply, injection pump and nozzle, and conducting 
collector. 2000
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Figure 1.  Plot of annual research publications concerning 
electrospinning studies. Search data from http://www.scopus.
com, years 2000–2011, using “electrospinning” or “electrospun,” 
as article title, abstract, or keywords.Shin et al.  3
studies on bone regeneration, which will be further dis-
cussed in section “Development of materials.” Recently, 
another specific use of the core–shell design for hard tis-
sues has been identified.16 A silica-based inorganic phase 
was overlapped with the inner biopolymer portion to 
improve the surface properties, such as hydrophilicity and 
an initial biological response. This system is considered 
interesting not only for improving cell response but also 
for its mechanical aspects, as the layered structure of a 
hard/soft material will generally sustain greater damage, as 
this has been found in engineering and medical designs 
like dental crowns.17 In fact, the core–shell design pro-
duced by electrospinning has great potential for enabling 
the use of nanofibers in drug delivery systems. Many 
attempts have been made to encapsulate therapeutics 
within the core portion of a nanofiber. However, careful 
designs are required to avoid degradation of the biological 
molecules to be delivered during the process of electro-
spinning because such processes require the use of organic 
solvents (mostly polymers) or treatment with high tem-
peratures (in the case of inorganics). Therefore, the use of 
water-soluble materials as the core part of the nanofiber is 
preferred to load drugs safely and to maintain long-lasting 
biological stability.18 The drug release pattern can be influ-
enced by several factors, including the composition and 
chemical properties of core and shell materials and the 
shell thickness and degradability. The most commonly 
used core materials are water-soluble polymers or proteins, 
including poly(ethylene glycol) (PEG), collagen, and 
bovine serum albumin (BSA).19,20 Poly (ε-caprolactone) 
(PCL) nanofibers with a core portion consisting of a PEG-
incorporating platelet-derived growth factor-BB 
(PDGF-BB) have shown sustained release for up to 2 
months while retaining biological activity of the growth 
factor, and the release was largely dependent on the molec-
ular weight of the PEG.19 When BSA was used as the core 
material incorporating nerve growth factor ensheathed 
with a synthetic copolymer of poly(lactic acid) (PLA) and 
PCL, the growth factor was also well protected and shown 
to have a near zero-order release pattern over time. This 
was in direct contrast to the initial burst release over a day 
observed in the nanofibers made by incorporating growth 
factor directly within the mixture of BSA/polymer,20 thus, 
confirming that the shell plays a crucial role in establishing 
the molecular diffusion path and sustaining the release of 
growth factor.
Designs for macropore generation
One of the significant challenges in the electrospinning 
process is the difficulty in creating macropores that are 
large enough to allow cellular migration and tissue perfu-
sion.4 This is particularly an issue in tissue engineering of 
large-sized defects. The pores to be generated by the elec-
trospinning are well within the range of fiber diameters, 
that is, tens of nanometers or at most a few micrometers. 
Some reports have shown the penetration of tissue cells in 
vitro through the nano/microporous channels of electro-
spun fibrous mats21; however, gaining sufficient cellular 
penetration for tissue-engineered construct has largely been 
limited. Tissue penetration in vivo has also been reported in 
thin tissues such as skin and blood vessels, where the scaf-
fold thicknesses were less than a few millimeters.22,23 To 
tissue-engineer bone tissues with large defect sizes distri-
bution of cells through the depth of nanofibers needs to be 
improved. Some studies have exploited the generation of 
macropores within the nanofibrous structure.24–27 Nam 
Figure 3.  Random and aligned electrospun nanofibers (PLCL synthetic biopolymer) influencing the direction of cellular spreading 
and elongation. Courtesy of Dr. Park JS in Medical College of Dankook University
PLCL: poly(lactide-co-caprolactone).
Figure 4.  Core–shell nozzle design used to encapsulate drugs 
within the nanofiber.4  Journal of Tissue Engineering 3(1)
et al.24 attempted to use sodium chloride particles as a poro-
gen. The salt particles were added during the process of 
electrospinning to be dispersed in the PCL polymer nanofi-
brous mesh, after which the particles were dissolved to 
leave porous spaces. After culture for 3 weeks, cell infiltra-
tion of up to 4 mm was observed. Another report described 
using microfibers as a framework of the porous scaffold, on 
which the nanofibrous mesh was electrospun to form a 
nanofiber-networked microfibrous scaffold.25 Osteoblast-
like cell lines and bone marrow stromal cells were shown to 
favor the nanofiber/microfiber scaffold for their prolifera-
tion and production of alkaline phosphatase. Another dual 
scale scaffold made of nanofibers and microfibers was also 
designed by combining the processes of polymer melt dep-
osition with electrospinning.26 A nanofibrous layer was 
electrospun upon each layer of the microfiber-structured 
surface, and the process was repeated to produce a nano–
microfibrous scaffold.26 While the approach will produce 
nanofibrous morphology on the microporous scaffold 
structure, the methodology is considered to have limita-
tions as it is not easily accessible and requires painstaking 
work to produce large-scale scaffolds. Another report used 
predesigned electrically conducting molds where the elec-
trospun nanofibers were collected to form a three-dimen-
sional (3D) scaffold network; however, this approach also 
has limitations for generating thick structures of the scaf-
folds.27 In this sense, the use of thick nanofibrous matrices 
with 3D complex shapes is still considered a great chal-
lenge in realizing hard-tissue engineering using nanofi-
brous scaffolds.
Development of materials
Hybrids and nanocomposites
The materials used in the development of electrospun 
nanofibers are considered to have properties that are spe-
cifically suitable for the calcified hard tissues, in terms of 
mechanical and biological aspects. The preferred composi-
tion would mimic the native ECM, so cells could recognize 
and utilize the artificial substrate during the regeneration 
process.28 The ECMs of hard tissues typically form a 
nanoscale organized composite between the inorganic and 
organic ingredients. While hydroxyapatite (HA) nanocrys-
tals are the major constituent of the composite inorganic 
materials, the organic constituents are much more variable 
and depend on the tissues (bone, dentin, and enamel), 
although fibrous collagen protein forms the main structural 
network.29 Mechanically, the organic network provides 
resilience, while the inorganic crystals harden the matrix, 
consequently, contributing to a strong and tough ECM.30 
The calcification process and the calcified structure are 
thus the essential traits of hard tissues. Therefore, it is ben-
eficial that the presence of an artificial matrix facilitates the 
calcification process. The use of bioactive ceramics such as 
calcium phosphate crystals and glasses with bioactive or 
soluble compositions has thus assisted in the in vitro and in 
vivo calcification processes by being directly involved in 
the formation of the hard tissue.
In this sense, the use of bioactive inorganics with biopol-
ymers (natural or synthetic) is considered a promising strat-
egy to develop artificial matrices for hard-tissue 
regeneration. Electrospinning of the composite solutions, 
however, is not easily implemented in the formation of a 
nanofibrous structure. In many cases, fibers become dis-
continuous and beads form and destroy continuous nanofi-
brous morphology, mainly due to the involvement of 
inorganic crystals. Therefore, one of the biggest considera-
tions in the composite electrospinning process is how to 
prepare fine nanocrystalline particles and then disperse 
them homogeneously within the polymer solution. For 
example, when HA crystals of approximately hundreds of 
nanometers were directly dispersed in a hydrophobic PLA 
solution, many large-sized beads were formed, thus limit-
ing the formation of a nanofibrous structure.31 However, 
when HA crystals of tens of nanometers in size were devel-
oped and then homogeneously dispersed by using a sur-
factant that mediates the interface of the hydrophilic 
nanocrystals and the hydrophobic solution, a uniform-
sized, bead-free fibrous morphology could be achieved.31 
Instead of using HA crystals, ultrafine-sized CaCO3 parti-
cles have also been successfully incorporated within the 
biopolymer composition to form an electrospun fiber.32 
Subsequently, many articles have reported nanocomposite 
electrospinning using biodegradable synthetic polymers 
with bioactive inorganic nanoparticulates, such as trical-
cium phosphate and bioactive glasses, and most of the 
nanocomposite nanofibers demonstrated some improve-
ment in the mechanical properties and/or bone cell 
functions.
The use of natural polymers with inorganics is consid-
ered to better mimic the native hard-tissue structure.33–35 
For this reason, HA was precipitated in situ from the Ca and 
P precursors within the gelatin or collagen solution, which 
was then subsequently electrospun into a nanofibrous 
mesh.33,35 High-resolution electron microscopy revealed 
the ultrafine nanocrystals of a bone mineral–like phase 
evenly distributed within the natural polymer matrix in a 
nanofibrous scaffold. The nanofibers containing apatite 
nanocrystals demonstrated better osteoblastic cell behavior, 
particularly at the stages of functional differentiation and 
mineralization.
Although the bioactive inorganics in particle forms 
were first considered as a composite source of hard-tissue 
matrices, the size of the particles, their homogeneity/dis-
persibility, and the added amount have still been an issue 
to improve for the successful electrospinning. For these 
reasons, the chemical hybridization of inorganic–organic 
compositions has also been pursued. As one example, a 
silicon-based inorganic precursor Shin et al.  5
(glycidoxypropyl trimethoxysilane) was homogenized 
with a natural polymer gelatin, which was then aged to 
form siloxane groups and linkages with the amino acids of 
gelatin to generate a hybridized structure.36 The siloxane–
gelatin material was electrospun into a continuous 
nanofiber under adjusted conditions, and the hybrid 
nanofiber showed an excellent ability to form bone min-
eral and demonstrated improved osteoblastic activity in 
vitro, thus proving to be a candidate substrate for bone 
regeneration.36 Another recent study also used synthetic 
polymer PCL in concert with bioactive glass in a ternary 
phase, where the PCL solution was mixed with a sol–gel 
solution based on tetraethyl orthosilicate and then electro-
spun into a nanofiber.37 Although no biological perfor-
mance was reported in the study, the nanofiber demonstrated 
hybridization, with hydrogen bonding between the organic 
and inorganic phases and uniform element distribution.
In the electrospinning process of the hybrid composi-
tions, a certain level of sol–gel reactions, such as the 
hydrolysis and condensation, is involved. Therefore, care-
ful consideration must be given to controlling the sol prop-
erties, which are dependent on time duration. Moreover, 
care must be given to maintaining the initially generated 
fibrous morphology of electrospun products without prod-
uct disintegration, which can be associated with hydration 
and gelation. Compared to the composite approach, there 
have been relatively few reports on hybrid nanofibers, 
which remain of significant interest, because the hybridiza-
tion process involves chemical reactions at the molecular 
scale, and thus, the organic–inorganic hybrids often show 
unexpected performance regarding their physicochemical 
and mechanical properties.
Surface mineralization of nanofibers
Many electrospinning materials are chosen from the poly-
meric compositions rather than from the inorganics, mainly 
due to mechanical factors. While inorganic nanofibers are 
generally brittle38,39 polymeric nanofibers are flexible and 
can be easily handled and manipulated for studies. 
Degradable synthetic polymers are thus preferred for use as 
a nanofibrous mesh for culturing cells in a variety of areas, 
including hard tissues. However, the surfaces of synthetic 
polymers are largely hydrophobic, not providing conditions 
favorable for cell adhesion.
One fascinating approach is to modify the surface of the 
polymer with a bone mineral–like phase, usually calcium-
deficient HA.40–44 The existence of the mineral phase on 
the surface of a nanofiber is considered to provide a sub-
strate favorable for bone-related cells, not only in the ini-
tial adhesion but also in further matrix synthesis. Compared 
to natural polymers such as collagen and chitosan, which 
have numerous ionic molecular groups, the synthetic poly-
mers have relatively few of these groups, which makes it 
highly difficult to induce mineralization. Thus, the surface 
treatment of the synthetic polymer nanofibers has been 
pursued in many different ways. The key is to expose 
hydroxyl or carboxyl groups by breaking down the poly-
mer chains, and this is possible by treatment in alkaline 
solution or by irradiation with high-energy sources. The 
exposed chemical groups are then ready to induce miner-
alization by further treatment in solutions containing cal-
cium and phosphate ions. One example of a mineralization 
strategy in PCL nanofibers is shown in Figure 5, where the 
PCL surface is activated in alkaline solution, followed by 
calcium phosphate nucleation through soaking in a solu-
tion containing calcium and phosphate, followed by fur-
ther incubation in a body-simulating medium to form a 
crystallized bone mineral–like phase.40 The addition of a 
natural polymer such as collagen within the synthetic poly-
mer PLA nanofiber was shown to accelerate apatite miner-
alization on the surface when the fiber was alternatively 
soaked in calcium and phosphate solutions.44 Cui et al.45 
treated the polymer surface with specifically engineered 
functional groups, such as hydroxyl, carboxyl, and amino 
groups, while varying the ratio of each group, and the sub-
sequent mineralization behavior was observed. Depending 
on the functionalized groups, the crystal size and intensity 
of the mineralized phase were different, reflecting the 
importance of the charge density of groups on the fiber 
surface and the interaction intensities among correspond-
ing ionic groups and/or polar groups. All the mineralized 
nanofibers were demonstrated to improve the proliferation 
and osteogenic differentiation of MC3T3-E1 cells, again 
proving the mineralized nanofibers to be a promising sub-
strate for hard-tissue regeneration.
The existence of bioactive inorganics, such as bioac-
tive glass nanocomponents and calcium phosphate parti-
cles within the synthetic polymer nanofibers, has been 
Figure 5.  Surface-mineralized PCL nanofiber as a matrix for 
hard-tissue regeneration.
PCL: poly-ε-caprolactone.6  Journal of Tissue Engineering 3(1)
shown to improve the surface mineralization process.46 
The inorganic phases can provide nuclei sites for the ini-
tiation of mineralization, and the release of ions (such as 
calcium, phosphate, and silicon) form the inorganics helps 
the precipitation of surface minerals. 
The mineralized surface provides an excellent sub-
strate for the initial adherence and spreading of precursors 
and/or stem cells and their later growth and differentiation 
to form bone-specific cells because the surface was func-
tionalized to largely mimic the native bone mineral. Upon 
the mineralized surface, adhesive proteins are also favored 
to anchor, thus providing conditions for cells to recognize 
the surface.47,48 Cells supported on the mineralized sur-
face are managed to synthesize ECMs that are more rele-
vant to the development of bone tissue, such as collagen 
type I, alkaline phosphatase, osteopontin, osteocalcin, and 
so on. The mineralized surface also plays a direct role in 
the cellular mineralization process, by providing a min-
eral source for calcification.
Applications with therapeutic 
potential
The potential of biomedical materials for use in hard-tissue 
regeneration can be greatly improved by combining bioac-
tive molecules, such as native proteins and chemical drugs. 
The appropriate use of such bioactive molecules is thus one 
of the key strategies to produce artificial scaffolds with 
therapeutic efficacy and a tissue-mimicking structure. It is 
considered that such molecules can be administered on the 
surface or inside of the nanofibrous matrices. When sup-
ported on the surface of the nanofiber, the bioactive mole-
cules will be in contact with the cells and thus be able to 
regulate initial cellular events. On the other hand, when 
incorporated within the nanofibers, the molecules inside 
are protected from the initial biological reactions, and the 
nanofibers are able to sustainably release a therapeutic 
substance over long periods of time. In this case, however, 
special precautions must be taken during the processing of 
nanofibers to protect the incorporated bioactive substances 
from being degraded. Specifically for hard tissues, surface-
mineralized nanofibers are considered to provide effective 
substrate conditions for retention of certain therapeutics 
and subsequent sustained release. Three key strategies to 
utilizing bioactive molecules are schematically shown in 
Figure 6.
A great deal of efforts have been given to utilize the 
adhesive proteins, such as fibronectin (FN), vitronectin, 
laminin, and collagen, in combination with the biopolymer 
nanofibers.49-54 Those proteins are the key molecules that 
mediate initial adhesion events in anchorage-dependent 
cells, which then further regulate intracellular signaling 
processes that are involved in cell spreading, migration, 
mitosis, differentiation, and death.50 Therefore, the pres-
ence of adhesive proteins on the biopolymer nanofibers 
facilitates initial cell adhesion because most synthetic poly-
mers are highly hydrophobic and lack an adhesive motif, 
which favors initial cellular events.51 However, the direct 
adsorption of proteins on the synthetic polymer is greatly 
limited; thus, the surface of the polymer needs to be   
activated to allow formation of chemical bonds with   
the proteins. Kim et al.52 aminated the surface of a 
poly(lactide-co-glycolide) (PLGA) polymer nanofiber and 
then coupled it with Gly-Arg-Gly-Asp-Tyr (GRGDY) pep-
tide. They showed a great enhancement of cell attachment, 
spreading, and proliferation on the peptide grafted 
nanofiber. The treatment of poly(lactide-co-caprolactone) 
(PLCL) nanofibers with NaOH was also shown to activate 
the biopolymer surface with numerous carboxyl and 
hydroxyl groups, which can form covalent linkages with 
the recombinant FN domain (FN9–10) through a carbodiim-
ide cross-linking process.54 The initial cellular events, 
including attachment and spreading, were significantly 
improved by the treatment, as shown in one of the results in 
Figure 7.
Figure 6.  Strategies for utilizing bioactive molecules in concert with nanofibrous matrices for bone regeneration; (a) adhesive 
proteins tethered on the nanofiber surface, (b) growth factors or drugs incorporated within the nanofiber, and (c) bioactive 
molecules incorporated within the mineralized surface of the nanofiber.Shin et al.  7
Apart from the adhesion proteins that are mainly 
involved in the initial cellular processes, many other bioac-
tive molecules have been implicated to have great impacts 
on the regeneration processes of bone defects. The most 
studied and promising of these molecules are the growth 
factors, which include bone morphogenetic proteins 
(BMPs), fibroblast growth factors (FGFs), transforming 
growth factors (TGFs), PDGFs, and insulin-like growth 
factors (IGFs). Because these proteins are susceptible to 
denaturation under processing conditions involving high 
temperatures, low pH, and organic solvents, special atten-
tion must be given to the incorporation process within the 
nanofibers. Therefore, natural polymers that are soluble in 
water-based solutions are usually favored for delivery of 
growth factors. Kaplan’s group has explored the delivery of 
BMP-2 within a silk fibroin–based nanofiber scaffold for 
bone regeneration.55 They directly added BMP-2 to a silk/
polyethylene oxide solution either containing HA or not 
containing HA and then electrospun the solution into fibers. 
The addition of BMP-2 significantly improved the osteo-
genic response of human MSCs, as deduced from gene lev-
els and cellular calcification, thus showing the efficacy of 
BMP-2 within the nanofiber matrix. Although the release 
behavior of BMP-2 from the nanofiber matrix and the 
mechanism of action were not detailed in the study, the 
silk-fibroin nanofibers were proposed as efficient carriers 
of BMP-2. Casper et al.56 used heparin to produce a high 
affinity for growth factors, including FGF. PEG nanofibers 
retaining heparin demonstrated a fairly good sustained 
release of basic FGF (bFGF) during a period of approxi-
mately 14 days.
Apart from proteins, nucleic acids may also be deliv-
ered by polymer nanofibers. Luu et al.57 incorporated plas-
mid DNA contained within PLA–PEG copolymer 
nanofibers and showed that the system released 80% of the 
gene content after 20 days. When the gene was transfected 
into the osteoblastic cells, an improvement in the transfec-
tion efficiency was noticed for the DNA incorporated by 
using nanofibers compared to the efficiency using a naked 
plasmid DNA, which was, however, lower than the effi-
ciency obtained using a commercial transfection reagent. 
Generally, genes are very sensitive to their surrounding 
biological conditions; therefore, it is important to maintain 
a stable biological environment. Liang et al.58 incorporated 
DNA into a PLA–PEG–PLA block copolymer during the 
electrospinning process and showed significantly enhanced 
transfection efficiency when the cells were cultured on the 
nanofiber. In a recent similar study, Nie et al.59 developed 
BMP-2 plasmid DNA–chitosan nanoparticles within a 
PLGA–HA nanofiber matrix for bone regeneration.
In addition to biological molecules, some chemical 
drugs such as antimicrobial and anticancer agents have 
been introduced into nanofiber scaffolds to enhance their 
therapeutic efficacy. Tetracycline hydrochloride for perio-
dontal use was loaded within a mixture of polymers (PLA 
and poly(ethylene-co-vinyl acetate) (PEVA). The incorpo-
rated tetracycline was rapidly released within 10–12 h, and 
the release rate was controlled by a change in the composi-
tion.60 The incorporation of hydrophobic drugs such as 
paclitaxel was made possible by mixing the drug with 
hydrophobic polymers.61,62 In addition to the type of poly-
mer used to encapsulate the drugs, the strength of the poly-
mer–drug interaction also greatly affects the drug release 
rate.63 As an antibacterial agent, silver nanoparticles have 
been incorporated within polymeric nanofibers.64 The sil-
ver nanoparticles embedded within the nanofiber matrix 
exhibited antibacterial efficacy against several types of 
bacteria.
Compared to the natural polymers, synthetic polymers 
are usually soluble in organic solvents, which would pre-
sent harsh conditions for proteins. Therefore, a more gen-
eral strategy for the safe delivery of proteins without 
regard to the encapsulating material would employ a 
core–shell nanofibrous structure composed of two con-
centric nozzles, as was mentioned in previous section.65,66 
The core materials are thus water soluble and can safely 
Figure 7.  Improvement of cell adhesion on the PLCL nanofiber by surface functionalization with adhesive ligand FN9–10 (bone 
marrow–derived mesenchymal stem cells on FN–PLCL vs. PLCL after 3 h of culture). Cells were more flattened and elongated in 
spreading behavior on the FN-tethered PLCL nanofiber than those on the pure PLCL nanofiber.
PLCL: poly(lactide-co-caprolactone); FN: fibronectin.8  Journal of Tissue Engineering 3(1)
hold proteins, and the shell portion shielding the encapsu-
lated proteins is favored to be biocompatible to comprise 
the surface structure of the nanofiber scaffolds. Therefore, 
design parameters, such as the type of core–shell materi-
als and the thickness and microstructure of the shell, 
greatly influence the release pattern of the proteins con-
tained inside; likewise, the release behaviors need to be 
interpreted by those parameters. A recent study described 
the use of nanofibers for bone regeneration by designing a 
core–shell structure consisting of a poly(ethylene oxide) 
(PEO) core incorporating BMP-2, which was encapsu-
lated by a PCL–PEG-blended polymer shell.67 Release 
profiles showed substantial sustained release of BMP-2 
and were highly dependent on the blended composition 
and the pores produced in the shell. Moreover, the core–
shell-structured nanofibers incorporating BMPs promoted 
human MSCs induction into an osteoblastic lineage, as 
well as in vivo bone regeneration in cranial defects, sug-
gesting the performance of the therapeutically developed 
nanofibers. Porogen contained in the shell portion of the 
nanofiber could be used to modulate the drug release 
kinetics.68 The mineralized surface, along with its direct 
influence on the action of cells related to hard-tissue 
regeneration, is considered to be a promising focus of 
research for the capture of biomolecules and drugs, and 
especially for drugs that have a high affinity for bone min-
erals. Some examples are proteins such as osteocalcin, 
which are deeply involved in the in vivo mineralization 
process. The recognition of HA by osteocalcin is very spe-
cific at the molecular level, and thus, the bonds between 
them are strong.69 X-ray crystal structure analysis revealed 
that a negatively charged protein surface coordinates five 
calcium ions in a spatial orientation that is similar to that 
of calcium ions in a HA crystal lattice. Another example 
can be found in alendronate, which is a well-known drug 
used for the treatment of osteoporosis. Alendronate has 
high affinity for the HA crystal by forming bonds between 
its own phosphate groups and the calcium ions in HA.70 
Therefore, the administration of these therapeutic biomol-
ecules that have specific affinity to the mineral phase is 
believed to be another promising methodology, which can 
be further explored.
Although the idea of using nanofibrous matrices as 
delivery systems for therapeutic molecules has emerged 
during the last several years due to new designs of materi-
als and equipment, there have been relatively few studies 
reported yet, particularly with regard to bone-specific tri-
als and in vivo feasibility. Moreover, realizing therapeutic 
functions through the delivery systems that are relevant to 
the in vivo situations is somewhat complicated where 
many/a series of growth factors and biofactors are 
involved in the bone repair and regenerative processes. 
For this reason, the design of nanofibrous matrices for 
enabling delivery of multiple biofactors is an interesting 
area to follow.
Perspectives and conclusions
Significant technological and scientific advances have been 
made in the field of electrospinning for the repair and 
regeneration of tissues, including bone. Along with the 
ability to produce a tissue-mimicking nanofibrous struc-
ture, other factors such as ease of setup and versatility in 
tuning composition and morphology have made it possible 
to design electrospun nanofibrous matrices for target tis-
sues. The structural and compositional traits of bone ECM, 
namely, a type of nanocomposite comprised of inorganic 
and organic phases, account for the specific development of 
electrospun matrices for bone. Compared to other soft tis-
sues, bone tissue requires cellular mineralization or calcifi-
cation stages to function in a biologically and mechanically 
relevant manner.
The technological modifications of apparatus needed for 
alignment of nanofibers, core–shell design, and micro-/
macroporous structuring, which have been successfully 
developed for other tissue types, are also largely appropri-
ate for creating cellular matrices for bone-tissue regenera-
tion. The alignment status of nanofibrous ECMs should 
alter their cellular behavior and functions to resemble those 
of hard tissues, including matrix syntheses and mineral 
deposition. The use of core–shell nanofibers is highly effec-
tive for incorporating bone cell–targeting biomolecules 
within artificial matrices to better mimic the native tissue 
structure and to regulate osteogenic cell functions. The pro-
duction of appropriate tissue-engineered constructs requires 
further enlargement of nanofibrous pore structures to a 
level that permits cellular migration and tissue perfusion, 
which are especially relevant factors when targeting large 
bone defects. Although some recent studies have attempted 
to enable 3D shaping and macrochanneling of nanofibrous 
matrices, the associated scaffolding issues have not been 
fully solved, especially issues relevant to large-scale pro-
duction of electrospun matrices. 
Along with the technological advances, methods for tai-
loring of the materials into combined or novel composi-
tions are being pursued to improve the mechanical and 
biological properties that are appropriate for hard tissues. 
This may be made possible either by the introduction of 
inorganic nanocomponents within the polymeric nanofi-
brous structure or the chemical hybridization of the inor-
ganic–organic components in a one-solution pot. This 
nanocomposite/hybrid approach is preferred to the single 
component system because the former has often shown bet-
ter performance in mechanical and biological aspects, such 
as retention of stiffness and strength, as well as stimulation 
of osteogenic differentiation and bone regeneration. 
However, organization of the composition within a nanofi-
brous structure requires special care to generate a homoge-
neous compositional distribution without the disintegration 
of fiber morphology. Instead of adding inorganic phases 
within the polymeric matrices, tailoring of the polymer Shin et al.  9
surface with bone mineral–like nanocrystals is a promising 
approach, which provides a biointerface favorable for bio-
logical reactions, including protein adsorption, cellular 
adherence, and bone differentiation.
Biological performance of the artificial nanofibrous 
materials can be substantially enhanced when therapeutic 
biofactors are loaded and appropriately delivered to the site 
of action. Several designs have been tested for their ability 
to safely and effectively load the biofactors and deliver 
them in a sustainable and/or controllable manner. A core–
shell-structured nanofiber containing biofactors inside a 
water-friendly core material is one promising design. 
Encapsulation of the biofactors within nanocapsules, which 
are then sheltered by a nanofibrous sheath, is also a possi-
ble method that can be used to achieve safe loading and 
sustainable delivery of the therapeutic molecules. The con-
jugation of therapeutic drugs through bone-mineral affin-
ity/specificity is another new way to utilize the therapeutic 
agents in concert with nanofibrous matrices for bone regen-
eration. The concepts and ideas emanating from this thera-
peutic approach are still at early stages. Numerous 
proof-of-concept studies that target specific bone-regenera-
tion themes are still required.
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